Parents’ decision-making about the human papillomavirus vaccine for their daughters: I. quantitative results

Human Vaccines and Immunotherapeutics

Volumn 11, Issue 2, 2015, Pages 322-329

  Krawczyk, Andrea ^a,b   Knäuper, Bärbel ^a   Gilca, Vladimir ^c   Dubé, Eve ^c   Perez, Samara ^a,b   Joyal Desmarais, Keven ^b   Rosberger, Zeev ^a,b,d  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^d MCGILL UNIVERSITY   (Canada)

Author keywords

Cancer vaccine; Decision making; Human papillomavirus; Papillomavirus vaccine; Quantitative research; Social determinants of health; Vaccine attitudes

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; DECISION MAKING; DISEASE PREDISPOSITION; EDUCATION; FEMALE; HEALTH BEHAVIOR; HUMAN; MALE; PAPILLOMAVIRUS INFECTION; PARENTAL ATTITUDE; PARENTAL BEHAVIOR; QUESTIONNAIRE; VACCINATION; CANADA; CHILD; CROSS-SECTIONAL STUDY; MIDDLE AGED; NUCLEAR FAMILY; PAPILLOMAVIRUS INFECTIONS; PARENT; PATIENT ATTITUDE; PSYCHOLOGY; RANDOMIZATION; UTILIZATION;

ADULT; CHILD; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; HUMANS; MALE; MIDDLE AGED; NUCLEAR FAMILY; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PARENTS; PATIENT ACCEPTANCE OF HEALTH CARE; QUEBEC; RANDOM ALLOCATION; SURVEYS AND QUESTIONNAIRES; VACCINATION;

EID: 84929077825     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.1080/21645515.2014.1004030     Document Type: Article

References (69)

1. Arbyn M, Castellsagué X, de Sanjosé S, Bruni L, Saraiya M, Bray F, Ferlay J. Worldwide burden of cervical cancer in 2008. Ann Oncol 2011; 22:2675-86; PMID:21471563; http://dx.doi.org/10.1093/annonc/mdr015
2. Clifford GM, Smith JS, Plummer M, Munoz N, Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer 2003; 88:63-73; PMID:12556961; http://dx.doi.org/10.1038/sj.bjc.6600688
3. Eggertson L. Provinces weighing HPV vaccination of boys. Canadian Medical Association Journal 2012; 184:E250-1; PMID:22371513; http://dx.doi.org/10.1503/cmaj.109-4140
4. Immunization NACo. Update on Human Papillomavirus (HPV) Vaccines. In: Canada PHAo, ed. Can Commun Dis Rep, 2012; 38:1-62; Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/12vol38/acsdcc-1/index-eng.php
5. Ball SL, Winder DM, Vaughan K, Hanna N, Levy J, Sterling JC, Stanley MA, Goon PK. Analyses of human papillomavirus genotypes and viral loads in anogenital warts. J Med Virol 2011; 83:1345-50.
6. Shearer BD. HPV vaccination: Understanding the impact of HPV disease. Purple Paper: Natl Collaborating Centre Infect Dis 2011 [Internet]; 34:1-18. Available from: www.nccid.ca/files/Purple_Paper_Note_mauve/PP_34_EN.pdf
7. Marra C, Ogilvie G, Gastonguay L, Colley L, Taylor D, Marra F. Patients with genital warts have a decreased quality of life. Sex Transmitted Dis 2009; 36:258-60; http://dx.doi.org/10.1097/OLQ.0b013e318191a55e
8. National Advisory Committee on Immunization. Statement on human papillomavirus vaccine. Can Commun Dis Rep 2007 [Internet]; 33:1-32. Available from: http://www.phac-aspc.gc.ca/publicat/ccdr-rmtc/07vol33/acs-02/index-eng.php
9. Centers for Disease Control and Prevention. Quadrivalent human papillomavirus vaccine: Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Weekly Rep 2007; 56:1-24; PMID:17380109
10. Allen JD, Othus MK, Shelton RC, Li Y, Norman N, Tom L, del Carmen MG. Parental decision making about the HPV vaccine. Cancer Epidemiol Biomarkers Prev 2010; 19:2187-98; PMID:20826829; http://dx.doi.org/10.1158/1055-9965.EPI-10-0217
11. Brewer NT, Gottlieb SL, Reiter PL, McRee AL, Liddon N, Markowitz LE, Smith JS. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transmitted Dis 2011; 38:197-204; PMID:20838362; http://dx.doi.org/10.1097/OLQ.0b013e3181f12dbf
12. Cates JR, Shafer A, Carpentier FD, Reiter PL, Brewer NT, McRee A-L, Smith JS. How parents hear about human papillomavirus vaccine: Implications for uptake. J Adolesc Health 2010; 47:305-8; PMID:20708571; http://dx.doi.org/10.1016/j.jadohealth.2010.04.003
13. Dempsey AF, Abraham LM, Dalton V, Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann Epidemiol 2009; 19:531-8; PMID:19394865; http://dx.doi.org/10.1016/j. annepidem.2009.03.011
14. Gerend MA, Weibley E, Bland H. Parental response to human papillomavirus vaccine availability: Uptake and intentions. J Adolesc Health 2009; 45:528-31; PMID:19837361; http://dx.doi.org/10.1016/j. jadohealth.2009.02.006
15. Gottlieb SL, Brewer NT, Sternberg MR, Smith JS, Ziarnowski K, Liddon N, Markowitz LE. Human papillomavirus vaccine initiation in an area with elevated rates of cervical cancer. J Adolesc Health 2009; 45:430-7; PMID:19837348; http://dx.doi.org/10.1016/j. jadohealth.2009.03.029
16. Guerry SL, De Rosa CJ, Markowitz LE, Walker S, Liddon N, Kerndt PR, Gottlieb SL. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011; 29:2235-41; PMID:21288799; http://dx.doi.org/10.1016/j.vaccine.2011.01.052
17. Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papillomavirus vaccine. Cancer Epidemiol Biomarkers Prev 2009; 18:363-72; PMID:19190161; http://dx.doi.org/10.1158/1055-9965.EPI-08-0418
18. Reiter PL, Brewer NT, Gottlieb SL, McRee A-L, Smith JS. Parents’ health beliefs and HPV vaccination of their adolescent daughters. Social Science & Medicine 2009; 69:475-80; PMID:19540642; http://dx.doi.org/10.1016/j.socscimed.2009.05.024
19. Reiter PL, McRee A-L, Gottlieb SL, Brewer NT. Correlates of receiving recommended adolescent vaccines among adolescent females in North Carolina. Human Vaccines 2011; 7:67-73; PMID:21263224; http://dx.doi.org/10.4161/hv.7.1.13500
20. Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, Succop PA. Uptake of HPV vaccine: Demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008; 43:239-45; PMID:18710678; http://dx.doi.org/10.1016/j.jadohealth.2008.06.009
21. Ziarnowski KL, Brewer NT, Weber B. Present choices, future outcomes: anticipated regret and HPV vaccination. Prev Med 2009; 48:411-4; PMID:18996144; http://dx.doi.org/10.1016/j.ypmed.2008.10.006
22. Ogilvie G, Anderson M, Marra F, McNeil S, Pielak K, Dawar M, McIvor M, Ehlen T, Dobson S, Money D, et al. A population-based evaluation of a publicly funded, school-based HPV vaccine program in British Columbia, Canada: parental factors associated with HPV vaccine receipt. PLoS Med 2010; 7:e1000270; PMID:20454567; http://dx.doi.org/10.1371/journal. pmed.1000270
23. Grandahl M, Oscarsson M, Stenhammar C, Neveus T, Westerling R, Tyden T. Not the right time: why parents refuse to let their daughters have the human papillomavirus vaccination. Acta Paediatr 2014; 103:436-41; PMID:24460679; http://dx.doi.org/10.1111/apa.12545
24. Gottvall M, Grandahl M, Hoglund AT, Larsson M, Stenhammar C, Andrae B, Tyden T. Trust versus concerns-how parents reason when they accept HPV vaccination for their young daughter. Ups J Med Sci 2013; 118:263-70; PMID:23777602; http://dx.doi.org/10.3109/03009734.2013.809039
25. Gottvall M, Tyden T, Larsson M, Stenhammar C, Hoglund AT. Challenges and opportunities of a new HPV immunization program perceptions among Swedish school nurses. Vaccine 2011; 29:4576-83; PMID:21549793; http://dx.doi.org/10.1016/j.vaccine. 2011.04.054
26. Cooper Robbins SC, Bernard D, McCaffery K, Brotherton J, Garland S, Skinner SR. “Is cancer contagious?”: Australian adolescent girls and their parents: Making the most of limited information about HPV and HPV vaccination. Vaccine 2010; 28:3398-408; PMID:20199758; http://dx.doi.org/10.1016/j.vaccine. 2010.02.078
27. Waller J, Marlow LAV, Wardle J. Mothers’ attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev 2006; 15:1257-61; PMID:16835320; http://dx.doi.org/10.1158/1055-9965.EPI-06-0041
28. Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW. Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation. Prev Med 2013; 57:414-8; PMID:23732252; http://dx.doi.org/10.1016/j.ypmed.2013.05.013
29. Hendry M, Lewis R, Clements A, Damery S, Wilkinson C. “HPV? Never heard of it!”: A systematic review of girls’ and parents’ information needs, views and preferences about human papillomavirus vaccination. Vaccine 2013; 31:5152-67; PMID:24029117; http://dx.doi.org/10.1016/j.vaccine.2013.08.091
30. Walhart T. Parents, adolescents, children and the human papillomavirus vaccine: a review. Int Nurs Rev 2012; 59:305-11; PMID:22897180; http://dx.doi.org/10.1111/j.1466-7657.2012.00991.x
31. Rosberger Z, Perez, S, King L, Franco E Public perception: a significant challenge in the battle against HPV. Oncology Exchange 2013; 12:16-20.
32. Krawczyk A, Lau E, Perez S, Delisle V, Amsel R, Rosberger Z. How to inform: comparing written and video education interventions to increase human papillomavirus knowledge and vaccination intentions in young adults. J Am Coll Health 2012; 60:316-22; PMID:22559091; http://dx.doi.org/10.1080/07448481.2011.615355
33. Allen JD, Coronado GD, Williams RS, Glenn B, Escoffery C, Fernandez M, Tuff RA, Wilson KM, Mullen PD. A systematic review of measures used in studies of human papillomavirus (HPV) vaccine acceptability. Vaccine 2010; 28:4027-37; PMID:20412875; http://dx.doi.org/10.1016/j.vaccine.2010.03.063
34. Fu LY, Bonhomme L-A, Cooper SC, Joseph JG, Zimet GD. Educational interventions to increase HPV vaccination acceptance: A systematic review. Vaccine 2014; 32:1901-20; PMID:24530401; http://dx.doi.org/10.1016/j.vaccine.2014.01.091
35. Shapiro G, Joyal-Desmarais K, Perez S, Rosberger Z. A Response to Fu et al.’s “Educational Interventions to Increase HPV Vaccination Acceptance”. Vaccine 2014; 32:6342-4. Available from: http://www.sciencedirect.com/science/article/pii/S0264410X14013139
36. Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr 1974; 2:328-35.
37. Glanz K, Rimer BK, Viswanath K. Health behavior and health education: theory, research, and practice. San Francisco, CA: Jossey-Bass, 2008.
38. Janz NK, Becker MH. The health belief model: a decade later. Health Educ Q 1984; 11:1-47; PMID:6392204; http://dx.doi.org/10.1177/109019818401100101
39. Tanner-Smith EE, Brown TN. Evaluating the health belief model: a critical review of studies predicting mammographic and pap screening. Social Theory & Health 2010; 8:95-125; http://dx.doi.org/10.1057/sth.2009.23
40. Lau JTF, Yang X, Tsui HY, Kim JH. Prevalence of influenza vaccination and associated factors among community-dwelling Hong Kong residents of age 65 or above. Vaccine 2006; 24:5526-34; PMID:16716461; http://dx.doi.org/10.1016/j.vaccine.2006.04.014
41. Nexoe J, Kragstrup J, Sogaard J. Decision on influenza vaccination among the elderly: A questionnaire study based on the health belief model and the multidimensional locus of control theory. Scand J Prim Health Care 1999; 17:105-10; PMID:10439494; http://dx.doi.org/10.1080/028134399750002737
42. Statistics Canada. 2006 Census: Selected Demographic, Cultural, Educational, Labour Force and Income Characteristics, Mother Tongue, Age Groups and Sex for the Population of Canada, Provinces, Territories, Census Divisions and Census Subdivisions [Internet]. Ottawa (On): [cited 2014 August 1]. Available from: http://www12.statcan.gc.ca/census-recensement/2006/dp-pd/tbt/Rp-eng.cfm?LANGDE&APATHD3&DETAILD0&DIMD0&FL=A&FREE=0&GC=0&GID=0&GK=0&GRP=1&PID=99015&PRID=0&PTYPE=88971,97154&S=0&SHOWALL=0&SUB=0&Temporal=2006&THEME=70&VID=0&VNAMEE=&VNAMEF
43. Markowski F, Toth E, Auger D, Landry M, Mercier M. Vaccination contre le VPH. Québec (Qc): Flash Vigie: Bureau de surveillance et de vigie de la Direction de la protection de la santé publique du ministére de la Santé et des Services sociaux du Québec (Canada); 2011; 6: 1-2.
44. Bonanni P, Cohet C, Kjaer SK, Latham NB, Lambert PH, Reisinger K, Haupt RM. A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD. Vaccine 2010; 28:4719-30; PMID:20451636; http://dx.doi.org/10.1016/j.vaccine.2010.04.070
45. Gee J, Naleway A, Shui I, Baggs J, Yin R, Li R, Kulldorff M, Lewis E, Fireman B, Daley MF, et al. Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink. Vaccine 2011; 29:8279-84; PMID:21907257; http://dx.doi.org/10.1016/j.vaccine.2011.08.106
46. Haupt RM, Sings HL. The efficacy and safety of the quadrivalent human papillomavirus 6/11/16/18 vaccine Gardasil. J Adolesc Health 2011; 49:467-75; PMID:22018560; http://dx.doi.org/10.1016/j.jadohealth.2011.07.003
47. Olsson SE, Villa LL, Costa RL, Petta CA, Andrade RP, Malm C, Iversen OE, Hoye J, Steinwall M, Riis-Johannessen G, et al. Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine. Vaccine 2007; 25:4931-9; PMID:17499406; http://dx.doi.org/10.1016/j.vaccine.2007.03.049
48. Villa LL, Costa RL, Petta CA, Andrade RP, Paavonen J, Iversen OE, Olsson SE, Hoye J, Steinwall M, Riis-Johannessen G, et al. High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. Br J Cancer 2006; 95:1459-66; PMID:17117182; http://dx.doi.org/10.1038/sj.bjc. 6603469
49. Betsch C, Sachse K. Debunking vaccination myths: strong risk negations can increase perceived vaccination risks. Health Psyc 2013; 32:146-55; PMID:22409264; http://dx.doi.org/10.1037/a0027387
50. Krawczyk A, Perez S, King L, Vivion M, Dub e E, Rosberger Z. Parents’ decision-making about the human papillomavirus vaccine for their daughters: II. Qualitative Results. Hum Vaccin Immunother 2015; 11:21-8.
51. Leader AE, Weiner JL, Kelly BJ, Hornik RC, Cappella JN. Effects of information framing on human papillomavirus vaccination. Journal of Women’s Health 2009; 18:225-33; PMID:19183094; http://dx.doi.org/10.1089/jwh.2007.0711
52. Gîlca V, Duval B, Boulianne N, Dion R, De Serres G. Impact of the Quebec school-based Hepatitis B immunization program and potential benefit of the addition of an infant immunization program. The Pediatric Infectious Disease Journal 2006; 25:372-4; http://dx.doi.org/10.1097/01.inf.0000207468.04665.ad
53. Cooper Robbins SC, Bernard D, McCaffery K, Brotherton JML, Skinner SR. “I just signed”: Factors influencing decision-making for school-based HPV vaccination of adolescent girls. Health Psyc 2010; 29:618-25; PMID:21090894; http://dx.doi.org/10.1037/a0021449
54. Cox D, Sturm L, Cox AD. Effectiveness of Asking Anticipated Regret in Increasing HPV Vaccination Intention in Mothers. Health Psyc 2014; 33:1074-83; PMID:24611739; http://dx.doi.org/10.1037/hea0000071
55. Middleman AB, Tung JS. At what sites are parents willing to have their 11 through 14-year-old adolescents immunized? Vaccine 2010; 28:2674-8; PMID:20085835; http://dx.doi.org/10.1016/j.vaccine.2010.01.006
56. Petty TJ, Callahan ST, Chen Q, Edwards KM, Dempsey AF. Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females. Vaccine 2010; 28:5686-90; PMID:20600495; http://dx.doi.org/10.1016/j.vaccine.2010.06.051
57. Montaquila JM, Brick JM, Williams D, Kim K, Han D. A Study of Two-Phase Mail Survey Data Collection Methods. Journal of Survey Statistics and Methodology 2013; 1:66-87; http://dx.doi.org/10.1093/jssam/smt004
58. Trim K, Nagji N, Elit L, Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: A systematic review from 2001 to 2011. CA>Obstet Gynecol Int 2012; 2012:921236; PMID:21977039
59. Bouliane N BR, Audet D, Ouaki M. Enquête sur la couverture vaccinale des enfants de 1 an et 2 ans au Québec en 2012. Institut National de Sant[1]e Publique du Québec, 2013:1-223; http://www.inspq.qc.ca/pdf/publications/1651_EnquCouvVaccinEnfants1Et2Ans2012.pdf
60. Case A, Paxson C. Mothers and others: who invests in children’s health? J Health Econ 2001; 20:301-28; PMID:11373833; http://dx.doi.org/10.1016/S0167-6296(00)00088-6
61. Nation M, Crusto C, Wandersman A, Kumpfer KL, Seybolt D, Morrissey-Kane E, Davino K. What works in prevention. Principles of effective prevention programs. Am Psychol 2003; 58:449-56; PMID:12971191; http://dx.doi.org/10.1037/0003-066X.58.6-7.449
62. Stone EG, Morton SC, Hulscher ME, Maglione MA, Roth EA, Grimshaw JM, Mittman BS, Rubenstein LV, Rubenstein LZ, Shekelle PG. Interventions that increase use of adult immunization and cancer screening services: a meta-analysis. Ann Intern Med 2002; 136:641-51; PMID:11992299; http://dx.doi.org/10.7326/0003-4819-136-9-200205070-00006
63. Gravel G, Markowski F, Toth E. Vigie-Interventions. Québec (QC): Flash Vigie: Bureau de surveillance et de vigie de la Direction de la protection de la santé publique du minist ere de la Santé et des Services sociaux du Québec (Canada); 2013; 8:1-4.
64. Dillman DA. Mail and Telephone Surveys: The Total Design Method. New York: Wiley & Sons, 1978.
65. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: A randomized intervention study of written information about HPV. Pediatrics 2006; 117:1486-93; PMID:16651301; http://dx.doi.org/10.1542/peds.2005-1381
66. Krawczyk AL, Perez S, Lau E, Holcroft CA, Amsel R, Knauper B, Rosberger Z. Human papillomavirus vaccination intentions and uptake in college women. Health Psyc 2012; 31:685-93; PMID:22268713; http://dx.doi.org/10.1037/a0027012
67. The Society of Obstetricians and Gynaecologists of Canada. Human Papillomavirus (HPV) Awareness. Ottawa (Ontario): The Society of Obstetricians and Gynaecologists of Canada; 2011 [cited 2014 August 1]. Available from: http://www.hpvinfo.ca/health-careprofessionals/order-online
68. Fazekas KI, Brewer NT, Smith JS. HPV vaccine acceptability in a rural Southern area. J Womens Health 2008; 17:539-48; PMID:18370586; http://dx.doi.org/10.1089/jwh.2007.0489
69. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: Wiley & Sons, 2000.